Advertisement
UK markets close in 6 hours 5 minutes
  • FTSE 100

    8,394.12
    -30.08 (-0.36%)
     
  • FTSE 250

    20,776.55
    -96.78 (-0.46%)
     
  • AIM

    807.04
    -2.90 (-0.36%)
     
  • GBP/EUR

    1.1695
    -0.0003 (-0.03%)
     
  • GBP/USD

    1.2717
    +0.0011 (+0.09%)
     
  • Bitcoin GBP

    55,812.45
    +3,197.78 (+6.08%)
     
  • CMC Crypto 200

    1,527.24
    +38.70 (+2.60%)
     
  • S&P 500

    5,308.13
    +4.86 (+0.09%)
     
  • DOW

    39,806.77
    -196.82 (-0.49%)
     
  • CRUDE OIL

    79.16
    -0.64 (-0.80%)
     
  • GOLD FUTURES

    2,421.70
    -16.80 (-0.69%)
     
  • NIKKEI 225

    38,946.93
    -122.75 (-0.31%)
     
  • HANG SENG

    19,220.62
    -415.60 (-2.12%)
     
  • DAX

    18,685.45
    -83.51 (-0.44%)
     
  • CAC 40

    8,134.75
    -61.21 (-0.75%)
     

Here's What Key Metrics Tell Us About RenaissanceRe (RNR) Q1 Earnings

RenaissanceRe (RNR) reported $2.83 billion in revenue for the quarter ended March 2024, representing a year-over-year increase of 46.8%. EPS of $12.18 for the same period compares to $8.16 a year ago.

The reported revenue represents a surprise of +5.96% over the Zacks Consensus Estimate of $2.68 billion. With the consensus EPS estimate being $9.86, the EPS surprise was +23.53%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

ADVERTISEMENT

Here is how RenaissanceRe performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Net Claims and Claim Expense Ratio: 47.7% versus 49.8% estimated by four analysts on average.

  • Underwriting Expense Ratio: 30.2% versus the four-analyst average estimate of 31.7%.

  • Combined Ratio: 77.9% compared to the 82.2% average estimate based on four analysts.

  • Net Claims and Claim Expense Ratio - calendar year - Casualty and Specialty Segment: 67.1% compared to the 63.8% average estimate based on three analysts.

  • Underwriting Expense Ratio - Casualty and Specialty Segment: 32.5% versus 31.6% estimated by three analysts on average.

  • Combined Ratio - Casualty and Specialty Segment: 99.6% versus the three-analyst average estimate of 95.3%.

  • Revenues- Net premiums earned: $2.44 billion versus the four-analyst average estimate of $2.29 billion. The reported number represents a year-over-year change of +45.4%.

  • Revenues- Equity in earnings (losses) of other ventures: $14.13 million versus the four-analyst average estimate of $6.04 million. The reported number represents a year-over-year change of +48.2%.

  • Revenues- Net investment income: $390.78 million versus the four-analyst average estimate of $384.67 million. The reported number represents a year-over-year change of +53.6%.

  • Net premiums earned- Property: $936.08 million versus the three-analyst average estimate of $816.79 million. The reported number represents a year-over-year change of +36.2%.

  • Net premiums earned- Casualty and Specialty: $1.51 billion versus $1.42 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +51.8% change.

  • Revenues- Other income (loss): -$0.05 million versus $2 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -98.8% change.

View all Key Company Metrics for RenaissanceRe here>>>

Shares of RenaissanceRe have returned -5.7% over the past month versus the Zacks S&P 500 composite's -2.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

RenaissanceRe Holdings Ltd. (RNR) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research